VAREX IMAGING ROA 2015-2018 | VREX

Current and historical return on assets (ROA) values for VAREX IMAGING (VREX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. VAREX IMAGING ROA for the three months ending June 30, 2018 was 6.08%.
VAREX IMAGING ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-06-30 $0.04B $0.98B 4.18%
2018-03-31 $0.05B $0.99B 4.79%
2017-12-31 $0.05B $1.02B 5.47%
2017-09-30 $0.05B $1.04B 6.07%
2017-06-30 $0.06B $1.05B 7.85%
2017-03-31 $0.07B $0.69B 13.47%
2016-12-31 $0.07B $0.65B 20.84%
2016-09-30 $0.07B $0.62B 44.37%
2016-06-30 $0.05B $0.00B 32.19%
2016-03-31 $0.03B $0.00B 19.86%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.018B $0.698B
Varex Imaging Corporation is an innovator, designer and manufacturer of X-ray imaging components which include tubes, digital flat panel detectors and other image processing solutions. Its components are used in medical imaging as well as industrial and security imaging applications. The company operates primarily in North America, Europe and Asia. Varex Imaging Corporation is based in Salt Lake City, United States.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $125.111B 19.18
Abbott Laboratories (ABT) United States $123.927B 25.11
Stryker (SYK) United States $63.616B 23.98
Boston Scientific (BSX) United States $51.104B 25.83
Baxter (BAX) United States $32.759B 21.16
Zimmer Biomet Holdings (ZBH) United States $23.343B 15.14
Smith & Nephew SNATS (SNN) United Kingdom $15.929B 0.00
ResMed (RMD) United States $14.783B 28.19
Canopy Growth (CGC) Canada $9.096B 0.00
Perrigo (PRGO) Ireland $8.909B 13.52
Bio-Rad Laboratories (BIO) United States $8.086B 51.70
Aurora Cannabis (ACB) Canada $6.688B 36.63
Hill-Rom Holdings (HRC) United States $6.277B 19.90
Haemonetics (HAE) United States $5.440B 47.85
Insulet (PODD) United States $4.849B 0.00
ICU Medical (ICUI) United States $4.490B 25.04
Hutchison China MediTech (HCM) China $4.221B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.051B 0.00
Agios Pharmaceuticals (AGIO) United States $3.732B 0.00
Neogen (NEOG) United States $3.281B 49.69
National Vision Holdings (EYE) United States $3.207B 70.82
NuVasive (NUVA) United States $2.954B 27.49
Aphria (APHA) $2.817B 0.00
Quidel (QDEL) United States $2.479B 32.31
NxStage Medical (NXTM) United States $1.925B 0.00
Phibro Animal Health (PAHC) United States $1.446B 20.47
AtriCure (ATRC) United States $1.192B 0.00
Cardiovascular Systems (CSII) United States $1.046B 1507.50
PetIQ (PETQ) United States $0.849B 27.76
Meridian Bioscience (VIVO) United States $0.828B 26.38
OraSure Technologies (OSUR) United States $0.826B 46.52
Surmodics (SRDX) United States $0.787B 120.33
Eagle Pharmaceuticals (EGRX) United States $0.753B 24.16
Cerus (CERS) United States $0.715B 0.00
MacroGenics (MGNX) United States $0.702B 0.00
Omeros (OMER) United States $0.628B 0.00
Owens & Minor (OMI) United States $0.575B 6.50
Lantheus Holdings (LNTH) United States $0.572B 17.69
Insys Therapeutics (INSY) United States $0.548B 0.00
LeMaitre Vascular (LMAT) United States $0.526B 25.81
NanoString Technologies (NSTG) United States $0.455B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.401B 0.00
Quanterix (QTRX) United States $0.362B 0.00
Utah Medical Products (UTMD) United States $0.325B 20.99
Cytosorbents (CTSO) United States $0.306B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.266B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
BioLife Solutions (BLFS) United States $0.214B 289.75
Bovie Medical (BVX) United States $0.204B 0.00
Rockwell Medical (RMTI) United States $0.201B 0.00
Chimerix (CMRX) United States $0.162B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.156B 0.00
Fonar (FONR) United States $0.141B 7.11
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.091B 0.00
United-Guardian (UG) United States $0.079B 16.60
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.67
InfuSystems Holdings (INFU) United States $0.060B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
Neurotrope (NTRP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
Valeritas Holdings (VLRX) United States $0.025B 0.00
Myomo (MYO) United States $0.024B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00